MDxHealth SA (MDXH)
NASDAQ: MDXH · IEX Real-Time Price · USD
2.270
-0.090 (-3.81%)
At close: Jul 2, 2024, 3:59 PM
2.260
-0.010 (-0.44%)
After-hours: Jul 2, 2024, 4:44 PM EDT
MDxHealth Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MDxHealth stock have an average target of 7.50, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 230.40% from the current stock price of 2.27.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 7, 2024.
Analyst Ratings
The average analyst rating for MDxHealth stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 3 | 3 | 3 | 3 | 3 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +208.37% | Mar 7, 2024 |
BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +252.42% | Mar 7, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +164.32% | Nov 9, 2023 |
TD Cowen | TD Cowen | Buy Initiates $7 | Buy | Initiates | $7 | +208.37% | May 31, 2023 |
BTIG | BTIG | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +208.37% | May 16, 2023 |
Financial Forecast
Revenue This Year
85.77M
from 70.19M
Increased by 22.19%
Revenue Next Year
97.89M
from 85.77M
Increased by 14.13%
EPS This Year
-1.04
from -16.60
EPS Next Year
-0.70
from -1.04
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 88.6M | 104.0M | 122.9M | 137.0M |
Avg | 85.8M | 97.9M | 113.5M | 133.1M |
Low | 82.3M | 92.1M | 101.1M | 127.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 26.3% | 21.2% | 25.5% | 20.7% |
Avg | 22.2% | 14.1% | 15.9% | 17.3% |
Low | 17.3% | 7.4% | 3.2% | 12.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -0.99 | -0.65 | -0.28 | 0.08 |
Avg | -1.04 | -0.70 | -0.39 | 0.08 |
Low | -1.08 | -0.73 | -0.55 | 0.08 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | - |
Avg | - | - | - | - |
Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.